Advert for breast cancer gene test triggers inquiryBMJ 2007; 335 doi: https://doi.org/10.1136/bmj.39342.667176.DB (Published 20 September 2007) Cite this as: BMJ 2007;335:579
- Jeanne Lenzer
- New York
A controversial television advertisement in the United States encouraging women to undergo genetic testing to determine their risk of breast cancer has triggered an inquiry into claims made by the advertiser, Myriad Genetics.
The women in the advertisement appear to be in their early 20s to late 50s, and each says she has a relative with breast cancer. A couple of the women say they want to get “BRACAnalysis” to learn about their risk of breast cancer and “do something about it.”
Some cancer specialists say that this “direct to consumer” campaign is unnecessarily alarmist. A New York Times …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial